ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business deals

Japan's Kintetsu to sell 8 hotels to Blackstone for $550m

Properties in Osaka and Kyoto on offer as rail group reels from COVID hit

Japanese railway group Kintetsu is selling properties in Osaka and Kyoto to U.S. fund Blackstone. (Source photos by Tomoki Mera and Reuters) 

TOKYO -- Japanese railway company Kintetsu Group Holdings plans to sell eight hotels in Osaka and Kyoto to U.S. investment fund Blackstone Group for around 60 billion yen ($550 million), Nikkei has learned.

Kintetsu's financial performance has been hit by a decline in passengers for its railway business due to the coronavirus pandemic. It plans to improve its finances by selling the hotels, in addition to previously announced measures like layoffs and selling office buildings.

The hotels being sold include Hotel Kintetsu Universal City, which is near Universal Studios Japan in Osaka, and Miyako Hotel Kyoto Hachijo. After the sale, Kintetsu will lease and continue to operate the hotels, maintaining their current names and employees.

Kintetsu will continue to hold other hotels, including a resort hotel in Mie Prefecture's Iseshima area and the Osaka Marriott Miyako Hotel.

Kintetsu's sales for the April-December period halved from a year earlier. It swung to a 35.4 billion yen net loss, from a 31.3 billion yen profit a year earlier. Hotel visitors fell dramatically due to COVID-19.

Blackstone is one of the largest investment funds in the world and has a track record of investing in real estate. In January, it acquired a rental housing unit of Isetan Mitsukoshi Holdings.

The Kintetsu hotel deal marks a shift in its strategy, which has been mainly focused on investing in assets that are relatively resilient to the impact of COVID-19 such as residential property and logistics facilities. The deal signals that Blackstone is anticipating a recovery in hotel demand thanks to the distribution of vaccines.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more